Doxorubicin resistance in breast cancer is mediated via the activation of FABP5/PPARγ and CaMKII signaling pathway

Breast cancer is the most prevalent malignancy among women. Doxorubicin (Dox) resistance was one of the major obstacles to improving the clinical outcome of breast cancer patients. The purpose of this study was to investigate the relationship between the FABP signaling pathway and Dox resistance in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Nan-Nan, Ma, Xin-Di, Miao, Zhuang, Zhang, Xiang-Mei, Han, Bo-Ye, Almaamari, Ahmed Ali, Huang, Jia-Min, Chen, Xue-Yan, Liu, Yun-Jiang, Su, Su-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395833/
https://www.ncbi.nlm.nih.gov/pubmed/37538178
http://dx.doi.org/10.3389/fphar.2023.1150861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395833/
https://www.ncbi.nlm.nih.gov/pubmed/37538178
http://dx.doi.org/10.3389/fphar.2023.1150861

Ejemplares similares